Nantahala Capital Management, LLC 13D and 13G filings for Eagle Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-05 4:32 pm Purchase | 2024-10-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Nantahala Capital Management, LLC | 3,945,209 30.400% | 1,983,139 (+101.07%) | Filing |
| 2024-07-03 2:02 pm Purchase | 2024-06-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Nantahala Capital Management, LLC | 1,962,070 15.100% | 1,962,070 (New Position) | Filing |